Oncomine Comprehensive Plus panel Test Cost AED 39,000.0 | DNA Labs UAE
Welcome to DNA Labs UAE, a leading genetic laboratory offering the Oncomine Comprehensive Plus panel Test. This test is specifically designed to detect genomic alterations in solid tumors and is commonly used in clinical research for cancer treatment.
Test Name: Oncomine Comprehensive Plus panel Test
Components:
- Paraffin embedded tissue blocks
Price: 39,000.0 AED
Sample Condition: Tumor tissue
Report Delivery: 2-3 weeks
Method: NGS (Next-Generation Sequencing)
Test Type: Genetics
Doctor: General Physician
Test Department:
The Oncomine Comprehensive Plus panel Test can be done with a doctor’s prescription. However, please note that the prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad.
Test Details:
The Oncomine Comprehensive Plus panel Test is a next-generation sequencing (NGS) assay that targets over 500 cancer-related genes. It includes both DNA and RNA sequencing, allowing for the identification of somatic mutations, copy number alterations, gene fusions, and splice variants. This comprehensive panel is widely used in clinical research to identify potential therapeutic targets and biomarkers for cancer treatment.
The Oncomine Comprehensive Plus panel Test is manufactured by Thermo Fisher Scientific, a trusted name in the field of genetic testing.
For more information or to schedule an appointment for the Oncomine Comprehensive Plus panel Test, please contact DNA Labs UAE.
Test Name | Oncomine Comprehensive Plus panel Test |
---|---|
Components | Paraffin embedded tissue blocks |
Price | 39000.0 AED |
Sample Condition | Tumor tissue |
Report Delivery | 2-3 weeks |
Method | NGS |
Test type | Genetics |
Doctor | General Physician |
Test Department: | |
Pre Test Information | Oncomine Comprehensive Plus panel can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad. |
Test Details | The Oncomine Comprehensive Plus panel is a next-generation sequencing (NGS) assay designed to detect genomic alterations in solid tumors. It targets over 500 cancer-related genes and includes both DNA and RNA sequencing. The panel is designed to identify somatic mutations, copy number alterations, gene fusions, and splice variants. It is commonly used in clinical research to identify potential therapeutic targets and biomarkers for cancer treatment. The Oncomine Comprehensive Plus panel is manufactured by Thermo Fisher Scientific. |